Publication
Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma
Angel Casaco, Gerardo López, Iván García, José Arsenio Rodríguez, Ramsés Fernández, Javier Figueredo, Leonel Torres, Alejandro Perera Pintado, Juan Batista, René Leyva, Yamilé Peña, Zaida Amador, Addys González, Barbara Estupiñan, Marcos Coca, Abel Hernández, Miguel Puig, Marbelia Iglesias, Astrid Hernández, Mayra Ramos, Leyanis Rodriquez, Niurelkis Suarez
Cancer Biology & Therapy, March 2008, Taylor & Francis
DOI: 10.4161/cbt.7.3.5414